SMOKING 'FREE' MARKET

Tobacco industry responses to research linking smoking to carcinogenic p53 mutations mirror prior industry efforts to challenge the science linking smoking and lung cancer. The extent of tobacco industry involvement in p53 research and the potential conflict of interest discussed here demonstrate the need for consistent standards for the disclosure and evaluation of such potential conflicts in biomedical research.

The p53 tumour suppressor gene and the tobacco industry: research, debate, and conflict of interest - The Lancet January 14, 2005